Measuring twenty-three distinct biomarkers, the latest wearable from PNOĒ identifies how
Vetting medication samples for purity and sterility is a critical step in ensuring that independent
The federal government provides a larger total subsidy to the employer-based health insurance market than it does for the mortgage interest or charitable deductions. While most taxpayers spend weeks every spring hunting for receipts and documentation to lower their tax liability, the single most
The sophisticated methods used today to engineer life-saving medications and map complex genomes trace their lineage back to the purification of DNA-altering enzymes in Lehman’s mid-century laboratories. This recent passing of I. Robert Lehman, PhD, at the age of 101 at his home on the Stanford
When a machine interprets a patient’s life-altering medical scan, the silent question echoing
Patients living in remote regions like Northern New England often endure six to eight hours of
A clinician spends nearly two hours on documentation for every hour of direct patient care. This ratio reflects the broader operational pressures that health systems face as demand grows and…
Cancer care is changing. The standard approach of detecting cancer after it develops and then
Oncology does not have a data problem. It has a decision latency problem that keeps insights
Most public health models explain yesterday's outbreak. Leaders need systems that flag risk
Biotech and pharma sponsors struggle when dose decisions are made late, rest on narrow evidence, or
The October 1 deadline serves as a pivotal moment for 8,000 residents whose access to preventative care and health stability is tied to their current Medicaid status. As this date approaches, a significant shift in federal healthcare policy is set to take effect, threatening the medical security of
The death of Sean Robinson on June 24, 2026, has ignited a critical examination of the clinical
Healthcare providers and insurance companies are currently locked in an administrative arms race
